NCT00205946 The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity Status COMPLETED Phase PHASE1
NCT00205933 Behavioral Processes Underlying Reward Processing in Depression Status COMPLETED Phase N/A
NCT00191594 Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials Status COMPLETED Phase PHASE3
NCT00188942 A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder Status COMPLETED Phase PHASE4
NCT00188396 Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment Response Status COMPLETED Phase NA
NCT00182533 Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders Status TERMINATED Phase PHASE4
NCT00179257 The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram Status COMPLETED Phase PHASE3
NCT00168376 A Randomised Double-Blind Trial of Targeted Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder Status COMPLETED Phase NA
NCT00166296 Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients Status COMPLETED Phase PHASE2
NCT00157547 Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression Status COMPLETED Phase PHASE4
NCT00149825 Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome Status COMPLETED Phase PHASE2
NCT00146523 An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression Status COMPLETED Phase PHASE3
NCT00135421 Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder Status COMPLETED Phase PHASE1/PHASE2